← Eichor
Study identifier: NCT01898416 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors

Condition: The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an · Adjuvant Therapy on the Clinical Outcome of Patients With Desmoid Tumors After · Surgical Resection  ·  Sponsor: michal roll

PhasePhase 2
Planned participants140
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to evaluate the efficacy of preoperative 5-ALA oral administration and subsequently intraoperative tumor bed phototherapy with red light laser, as an adjuvant therapy on the 3 years rate of local tumor recurrence in patients with desmoid tumors. To evaluate the Safety of 5-ALA administration. 5 years local recurrence rate.

This description comes directly from the study's public registry record.

Talk to the study team

Jacob Bickels, MD/PhD  ·  +972-524266341  ·  jACOBB@TLVMC.GOV.IL

Always discuss trial participation with your own doctor first.

Locations (2)

Tel Aviv sourasky medical centerTel Aviv, Israel, IsraelRecruiting
The Aviv Sourasky Medical CenterTel Aviv, Israel, IsraelRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT01898416